99 related articles for article (PubMed ID: 29281039)
1. Assessing individual-level needle and syringe coverage parameters and the measurement of coverage in Melbourne, Australia: methods and impacts.
O'Keefe D; Scott N; Aitken C; Dietze P
J Public Health (Oxf); 2018 Sep; 40(3):e336-e342. PubMed ID: 29281039
[TBL] [Abstract][Full Text] [Related]
2. How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?
O'Keefe D; McCormack A; Cogger S; Aitken C; Burns L; Bruno R; Stafford J; Butler K; Breen C; Dietze P
Int J Drug Policy; 2017 Aug; 46():99-106. PubMed ID: 28667880
[TBL] [Abstract][Full Text] [Related]
3. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
O'Keefe D; Aitken C; Scott N; Dietze P
Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia.
O'Keefe D; Scott N; Aitken C; Dietze P
Drug Alcohol Depend; 2017 Jul; 176():7-13. PubMed ID: 28463684
[TBL] [Abstract][Full Text] [Related]
5. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.
Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L
Drug Alcohol Depend; 2019 Apr; 197():108-114. PubMed ID: 30802734
[TBL] [Abstract][Full Text] [Related]
6. Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.
McCormack AR; Aitken CK; Burns LA; Cogger S; Dietze PM
Am J Epidemiol; 2016 May; 183(9):852-60. PubMed ID: 27049004
[TBL] [Abstract][Full Text] [Related]
7. Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis.
O'Keefe D; Scott N; Aitken C; Dietze P
BMC Health Serv Res; 2016 Aug; 16(1):411. PubMed ID: 27542604
[TBL] [Abstract][Full Text] [Related]
8. Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar.
O'Keefe D; Aung SM; Pasricha N; Wun T; Linn SK; Lin N; Aitken C; Hughes C; Dietze P
Int J Drug Policy; 2018 Aug; 58():22-30. PubMed ID: 29754104
[TBL] [Abstract][Full Text] [Related]
9. Should sterile needle and syringe wastage be included within individual-level needle and syringe coverage measures?
Daniel O; Campbell A; Paul D
Int J Drug Policy; 2018 Oct; 60():8-9. PubMed ID: 30077904
[No Abstract] [Full Text] [Related]
10. Are there differences in individual-level needle and syringe coverage across Australian jurisdictions related to program policy? A preliminary analysis.
Hill P; O'Keefe D; Dietze PM
Drug Alcohol Rev; 2018 Jul; 37(5):653-657. PubMed ID: 29851167
[TBL] [Abstract][Full Text] [Related]
11. Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.
O'Keefe D; Wilkinson A; Aitken C; Dietze P
PLoS One; 2018; 13(12):e0209280. PubMed ID: 30550588
[TBL] [Abstract][Full Text] [Related]
12. Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.
Iversen J; Topp L; Wand H; Maher L
Drug Alcohol Depend; 2012 May; 122(3):195-200. PubMed ID: 22071120
[TBL] [Abstract][Full Text] [Related]
13. Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia.
O'Keefe D; Livingston M; Cossar RD; Kerr P; Jacka D; Dietze P
Harm Reduct J; 2022 Sep; 19(1):101. PubMed ID: 36071500
[TBL] [Abstract][Full Text] [Related]
14. "We get by with a little help from our friends": Small-scale informal and large-scale formal peer distribution networks of sterile injecting equipment in Australia.
Newland J; Newman C; Treloar C
Int J Drug Policy; 2016 Aug; 34():65-71. PubMed ID: 27449331
[TBL] [Abstract][Full Text] [Related]
15. Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia.
Schroeder SE; Wilkinson AL; O'Keefe D; Bourne A; Doyle JS; Hellard M; Dietze P; Pedrana A
Harm Reduct J; 2023 Jan; 20(1):9. PubMed ID: 36691010
[TBL] [Abstract][Full Text] [Related]
16. Measures of harm reduction service provision for people who inject drugs.
O'Keefe D; Bluthenthal RN; Kral AH; Aitken CK; McCormack A; Dietze PM
Bull World Health Organ; 2019 Sep; 97(9):605-611. PubMed ID: 31474773
[TBL] [Abstract][Full Text] [Related]
17. Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan.
Zule WA; Latypov A; Otiashvili D; Kirtadze I; Ibragimov U; Bobashev GV
Harm Reduct J; 2015 Oct; 12():37. PubMed ID: 26472669
[TBL] [Abstract][Full Text] [Related]
18. Estimating national-level syringe availability to injecting drug users and injection coverage: Switzerland, 1996-2006.
Arnaud S; Jeannin A; Dubois-Arber F
Int J Drug Policy; 2011 May; 22(3):226-32. PubMed ID: 21600753
[TBL] [Abstract][Full Text] [Related]
19. New needle and syringe use, and use of needle exchange programmes by street recruited injection drug users in 1993.
MacGowan RJ; Sterk CE; Long A; Cheney R; Seeman M; Anderson JE
Int J Epidemiol; 1998 Apr; 27(2):302-8. PubMed ID: 9602414
[TBL] [Abstract][Full Text] [Related]
20. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
Wilson H; Brener L; Mao L; Treloar C
Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
